HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroki Takagi Selected Research

Biguanides

1/2018Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroki Takagi Research Topics

Disease

2Infections
10/2020 - 11/2017
2Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 03/2015
2Nausea
01/2018 - 11/2015
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 11/2015
1Paralysis (Palsy)
03/2022
1Neoplasms (Cancer)
03/2022
1Alzheimer Disease (Alzheimer's Disease)
03/2022
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2022
1Tetraploidy
10/2021
1Polyploidy
10/2021
1Cysts
10/2021
1Hypoxia (Hypoxemia)
01/2021
1Autosomal Recessive 2 Spinocerebellar Ataxia
11/2020
1Cicatrix (Scar)
11/2020
1Eczema
04/2019
1Pruritus (Itching)
04/2019
1Male Infertility (Male Sterility)
12/2018
1Meningococcal Infections
11/2018
1Constipation
01/2018
1Body Weight (Weight, Body)
11/2015
1Diabetes Mellitus
03/2015
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2015
1Disease Resistance
10/2013
1Food Hypersensitivity (Food Allergy)
12/2006
1Atopic Dermatitis (Atopic Eczema)
12/2006
1Hypersensitivity (Allergy)
12/2006

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
11/2020 - 11/2017
3lixisenatideIBA
01/2018 - 03/2015
1BetalainsIBA
03/2022
1betaninIBA
03/2022
1Amyloid (Amyloid Fibrils)IBA
03/2022
1AntioxidantsIBA
03/2022
1Biological ProductsIBA
03/2022
1GangliosidesIBA
01/2022
1CholesterolIBA
01/2022
1CyclodextrinsIBA
01/2022
1GlycolipidsIBA
01/2022
1LactoseFDA LinkGeneric
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2022
1SphingomyelinsIBA
01/2022
1Anthocyanins (Anthocyanin)IBA
10/2021
1Genetic Markers (Genetic Marker)IBA
10/2021
1SilicatesIBA
01/2021
1Phosphotransferases (Kinase)IBA
10/2020
1Nuclear Proteins (Protein, Nuclear)IBA
10/2020
1Immunoglobulin A (IgA)IBA
04/2019
1F-Box ProteinsIBA
12/2018
1Polysaccharides (Glycans)IBA
11/2018
1Conjugate VaccinesIBA
11/2018
1Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link
11/2018
1BiguanidesIBA
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1Glycoside Hydrolase InhibitorsIBA
01/2018
1alpha-Glucosidases (Acid Maltase)IBA
01/2018
12,4-thiazolidinedione (thiazolidinedione)IBA
01/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2015
1Glucose (Dextrose)FDA LinkGeneric
11/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2015
1Glucagon-Like Peptide-1 ReceptorIBA
03/2015
1Metformin (Glucophage)FDA LinkGeneric
03/2015
1NucleotidesIBA
10/2013
1Leucine (L-Leucine)FDA Link
10/2013
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
12/2006
1InterleukinsIBA
12/2006
1Interleukin-10 (Interleukin 10)IBA
12/2006
1CytokinesIBA
12/2006
1Immunoglobulin E (IgE)IBA
12/2006

Therapy/Procedure

2Glycemic Control
01/2018 - 03/2015
1Therapeutics
01/2018